Please do not adjust margins
RSC Advances
Page 8 of 10
DOI: 10.1039/C5RA15996B
ARTICLE
Journal Name
J = 15.5 Hz, 1H), 7.56 (d, J = 8.5 Hz, 2H), 7.51 (d, J = 16 Hz, 1H), 7.38 1685, 1593, 1266, 1083, 864, 727. GC–MS (m/z): 318 [M+,
(d,
J = 8.5 Hz, 2H), 6.98 (d, J = 9
Hz, 2H), 5.48 (s, 1H, C15H11BrO3], 320 [M+2]+.
D2Oexchangeable), 3.89 (s, 3H). 13C NMR (CDCl3, 125 MHz, ppm) δ 2,6-diphenyltetrahydro-2H-pyran-4-ol (22a): 1H NMR (500 MHz,
188.2, 163.9, 142.7, 131.4, 131.3, 130.1, 121.5, 116.8, 116.6, 114.2, CDCl3, ppm): δ 7.19-7.41 (m, 8H), 4.51-4.43 (m, 2H), 4.07 (tt, J = 4.5,
55.1. IR νmax (KBr, cm-1): 3410, 2928, 2880, 1684, 1599, 1265. GC-MS 11.5 Hz, 1H), 2.28 (s, br, D2O exchangeable, 1H, OH), 2.21 (dd, J = 4,
(m/z): 254 [M+, C16H14O3].
(E)-1-(4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
11.5Hz, 2H), 1.53 (q, J = 11.5 Hz, 2H). 13C NMR (125 MHz, CDCl3,
ppm): δ 131.4, 128.3, 127.5, 125.8, 77.8, 68.6, 42.9. IR (KBr, cm-1):
(8a): 1H NMR (CDCl3, 500 MHz, ppm) δ 8.03 (d, J = 8 Hz, 2H), 7.77 (d, 3433, 2965, 2921, 2852, 1634, 1452, 1382, 1265, 1156, 1065, 900,
J = 16 Hz, 1H), 7.55 (d, J = 8Hz, 2H), 7.42 (d, J = 15.5 Hz, 1H), 6.98 (d, 760, 700. GC-MS (m/z): 410 [M+, C17H18O2].
J = 8 Hz, 2H), 6.89 (d, J = 8 Hz, 2H), 5.82 (s, 1H, D2O exchangeable), 2,6-bis(4-chlorophenyl)tetrahydro-2H-pyran-4-ol (23a): 1H NMR
3.89 (s, 3H). 13C NMR (CDCl3, 125 MHz, ppm) δ 188.7, 163.6, 142.8, (500 MHz, CDCl3, ppm): δ 7.29-7.24 (m, 8H), 4.47 (d, J = 11.5 Hz,
131.2, 131.0, 130.4, 121.7, 116.3, 116.2, 114.0, 55.7. IR (KBr, νmax
=
2H), 4.06 (tt, J = 4.5, 11.5 Hz, 1H), 2.19 (dd, J = 4, 11.5 Hz, 2H), 1.48
cm-1): 3410, 2926, 2875, 1686, 1599, 1265. GC-MS (m/z): 254 [M+, (q, J = 11.5 Hz, 2H). 13C NMR (125 MHz, CDCl3, ppm): δ 139.2, 132.3,
C16H14O3].
127.5, 126.2, 77.8, 67.4, 41.9. IR (KBr, cm-1): 3447, 2960, 2886,
1652, 1543, 1088, 804. GC-MS (m/z): 323 [M+, C17H16Cl2O2].
(E)-1-(2-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
1
(9a): H NMR (CDCl3, 400 MHz, ppm) δ 7.91-7.86 (m, 2H), 7.61 (d, J (E)-3-(4-(6-(4-chlorophenyl)-4-hydroxytetrahydro-2H-pyran-2-
= 8.8 Hz, 2H), 7.52 (d, J = 15.6 Hz, 1H), 7.49-7.45 (m, 2H), 7.00 (dd, J yl)phenyl)-1-(4-fluorophenyl)prop-2-en-1-one (24a): 1H NMR (500
= 1.2, 8.8 Hz, 1H), 6.93 (d, J = 8.4 Hz, 2H), 3.84 (s, 3H), 1.68 (s, 1H, MHz, CDCl3, ppm): δ 8.18 (d, J = 8 Hz, 1H), 7.95 (d, J = 8 Hz, 2H), 7.59
D2O exchangeable). 13C NMR (CDCl3, 100 MHz, ppm) δ 193.8, 163.7, (d, J = 9 Hz, 3H), 7.48 (d, J = 8 Hz, 2H), 7.41 (d, J = 9 Hz, 2H), 7.36 (d,
162.1, 145.5, 136.3, 130.7, 129.7, 127.4, 120.2, 118.9, 118.7, 117.7, J = 8.5 Hz, 2H), 7.01 (d, J = 9 Hz, 2H), 4.66 (t, J = 3 Hz, 2H), 4.14 (tt, J
114.6, 55.6. IR (KBr, νmax = cm-1): 3410, 2926, 2875, 1686, 1599, = 11, 3 Hz, 1H), 2.22-2.85 (m, 2H), 2.04 (s, br, D2O exchangeable,
1265. GC-MS (m/z): 254 [M+, C16H14O3].
1H), 1.73-1.84 (m, 2H). 13C NMR (125 MHz, CDCl3, ppm): δ 188.8,
(E)-1-(4-chlorophenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one (12a): 166.7, 164.6, 144.6, 143.7, 140.8, 134.5, 134.3, 131.2, 130.0,
1H NMR (CDCl3, 400 MHz, ppm) δ 7.92-7.84 (m, 2H), 7.64-7.58 (m, 128.7, 127.7, 126.5, 125.9, 121.6, 115.9, 78.0, 77.7, 69.4, 40.0. IR
3H), 7.53-7.49 (m, 1H), 7.41 (d, J = 8.8 Hz, 2H), 7.01 (d, J = 8.4 Hz, (KBr, cm-1): 3434, 3010, 2922, 2843, 1734, 1626, 1456, 1256, 1069,
1H), 6.95 (d, J = 7.2 Hz, 2H), 4.84 (s, 1H, D2O exchangeable). 13C 808.8. HRMS (ESIMS): for C26H22ClFNaO3 (M+Na)+ Anal. calcd.
NMR (CDCl3, 100 MHz, ppm) δ 193.6, 163.8, 144.1, 136.7, 133.2, 459.1139; found 459.1150.
131.7, 130.0, 129.8, 129.5, 129.0, 120.7, 119.1, 118.9. IR (KBr, νmax
=
(E)-1-(4-bromophenyl)-3-(4-(6-(4-bromophenyl)-4-
cm-1): 3410, 2926, 2875, 1686, 1599, 1265. GC-MS (m/z): 258 [M+, hydroxytetrahydro-2H-pyran-2-yl)phenyl)prop-2-en-1-one (25a):
C15H11ClO2], 260 [M+2]+.
1H NMR (500 MHz, CDCl3, ppm): δ 7.88 (d, J = 8 Hz, 2H), 7.82 (d, J =
8.5 Hz, 2H), 7.78 (s, 1H), 7.61-7.66 (m, 4H), 7.47 (s, 1H), 7.35 (d, J = 8
2,5-dihydroxy-3-(4-methoxyphenyl)-2,3-dihydro-1H-inden-1-one
1
(16a): H NMR (CDCl3, 500 MHz, ppm) δ 7.92 (dd, J = 1.5, 7 Hz, 2H), Hz, 2H), 7.31-7.32 (m, 2H), 4.45 (d, J = 32, 11.5 Hz, 2H), 4.07 (tt, J =
7.55-7.52 (m, 2H), 7.07-7.01 (m, 3H), 5.31 (d, J = 2 Hz, 1H), 5.22 (d, J 10.5, 3 Hz, 1H), 2.30-2.35 (m, 2H), 2.20 (s, br, D2O exchangeable,
= 2 Hz, 1H), 4.19 (s, 1H, D2O exchangeable), 3.91 (s, 3H), 1.61 (s, 1H, 1H), 1.77-1.86 (m, 2H). 13C NMR (125 MHz, CDCl3, ppm): δ 189.8,
D2O exchangeable). 13C NMR (CDCl3, 125 MHz, ppm) δ 195.9, 162.6, 143.7, 140.7, 135.4, 134.4, 134.1, 129.8, 129.2, 128.5, 128.4, 127.8,
162.2, 136.8, 134.8, 131.4, 129.3, 128.9, 125.6, 116.7, 115.8, 75.4, 127.5, 126.2, 125.7, 122.0, 77.8, 77.4, 67.2, 39.8. IR (KBr, cm-1):
63.6, 53.7. IR (KBr, νmax = cm-1): 3408, 2925, 2879, 1685, 1595, 1266, 3454, 2961, 2878, 1651, 1541, 1091, 801. HRMS (ESIMS): for
1089, 858, 731. GC-MS (m/z): 270 [M+, C16H14O4].
C26H22Br2NaO3 (M+Na)+ Anal. calcd. 562.9833; found 562.9853.
3-(4-bromophenyl)-2,5-dihydroxy-2,3-dihydro-1H-inden-1-one
2-(4-(4-hydroxy-6-phenyltetrahydro-2H-pyran-2-yl)phenyl)-4H-
(18a): H NMR (CDCl3, 500 MHz, ppm) δ 7.93 (m, 2H), 7.70-7.67 (m, chromen-4-one (26a): 1H NMR (500 MHz, CDCl3, ppm): δ 7.74 (d, J =
1H), 7.58-7.53 (m, 2H), 7.08-7.04 (m, 2H), 6.10 (s, 1H, D2O 8 Hz, 2H), 7.37 (dd, J = 6, 3 Hz, 2H), 7.27 (d, J = 8.5 Hz, 2H), 7.17-7.21
exchangeable), 5.37 (d, J = 2 Hz, 1H), 5.22 (d, J = 2.5 Hz, 1H), 4.15 (s, (m, 3H), 7.15 (d, J = 8.5 Hz, 2H), 6.92 (s, 1H), 6.79 (dd, J = 6.5, 3 Hz,
1H, D2O exchangeable). 13C NMR (CDCl3, 125 MHz, ppm) δ 195.6, 2H), 4.40 (t, J = 11.5 Hz, 2H), 3.90 (tt, J = 11, 3 Hz, 1H), 2.15-2.22 (m,
161.9, 137.4, 132.4, 131.9, 131.5, 130.0, 129.8, 126.0, 123.1, 116.3, 2H), 1.68-1.77 (m, 2H). 13C NMR (125 MHz, CDCl3, ppm): δ 190.0,
75.4, 63.6. IR (KBr, νmax = cm-1): 3433, 2935, 2877, 1687, 1585, 1266, 163.0, 156.0, 139.8, 135.5, 134.1, 131.6, 129.9, 129.3, 128.6, 128.6,
1
1088, 862, 733. GC-MS (m/z): 318 [M+, C15H11BrO3], 320 [M+2]+.
127.6, 127.5, 126.3, 122.2, 121.8, 77.1, 76.9, 65.0, 39.8, 39.7. IR
(KBr, cm-1): 3446, 2971, 2880, 1652, 1513, 1208, 799. HRMS
5-chloro-2-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-1H-inden-1-
one (20a): 1H NMR (CDCl3, 500 MHz, ppm) δ 7.92 (m, 2H), 7.68 (d, J (ESIMS): for C26H21NaO4 (M+Na)+ Anal. calcd. 421.1416; found
= 7.5 Hz, 1H), 7.58-7.50 (m, 2H), 7.43 (d, J = 8.5 Hz, 2H), 5.36 (d, J = 421.1441.
1.5 Hz, 1H), 5.19 (d, J = 2 Hz, 1H), 4.13 (s, 1H, D2O exchangeable), 2-(2-chlorophenyl)-2,3-dihydroquinolin-4(1H)-one (29a): 1H NMR
1.81 (s, 1H, D2O exchangeable). 13C NMR (CDCl3, 125 MHz, ppm) δ (500 MHz, CDCl3, ppm) δ 11.34 (s, 1H, D2O exchangeable), 8.58 (d, J
195.7, 162.4, 161.5, 136.7, 134.7, 131.4, 130.5, 129.4, 128.8, 125.3, = 6 Hz, 1H), 7.87 (dd, J = 10, 2.5 Hz, 1H), 7.75-7.79 (m, 1H), 7.59 (d, J
116.2, 75.4, 63.6. IR (KBr, νmax = cm-1): 3417, 2931, 2871, 1681, = 10 Hz, 1H), 7.44-7.48 (m, 1H), 7.26-7.29 (m, 1H), 6.98-7.03 (m,
1597, 1263, 1081, 860, 737. GC-MS (m/z): 274 [M+, C15H11ClO3], 276 2H), 5.60 (dd, J = 13.5, 6.5 Hz, 1H), 3.06-3.16 (m, 2H). 13C NMR (125
[M+2]+.
MHz, CDCl3, ppm) δ 191.2, 160.8, 157.1, 148.4, 138.3, 136.2, 127.1,
123.8, 121.9, 121.4, 121.2, 118.1, 79.1, 42.8. IR (KBr, cm-1): 3164,
5-bromo-2-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydro-1H-inden-1-
one (21a): H NMR (CDCl3, 500 MHz, ppm) δ 7.91 (dd, J = 1, 8 Hz, 2926, 1693, 1606, 1462, 1305, 763. GC-MS (m/z): 257 [M+,
1
2H), 7.70-7.67 (m, 1H), 7.58-7.54 (m, 2H), 7.43 (t, J = 8.5 Hz, 2H), C15H12ClNO], 259 [M+2]+.
6.10 (s, 1H, D2O exchangeable), 5.38 (d, J = 2 Hz, 1H), 5.22 (d, J = 2.5 2-(3,4-dimethoxyphenyl)-2,3-dihydroquinolin-4(1H)-one (33a): 1H
Hz, 1H), 4.15 (s, 1H, D2O exchangeable). 13C NMR (CDCl3, 125 MHz, NMR (500 MHz, CDCl3, ppm) δ 12.17 (s, 1H, D2O exchangeable),
ppm) δ 197.7, 163.9, 161.9, 134.5, 134.2, 133.6, 130.1, 130.0, 129.3, 7.93 (d, J = 10 Hz, 1H), 7.51 (t, J = 10.5 Hz, 1H), 7.01-7.08 (m, 4H),
128.7, 115.7, 76.1, 63.1. IR (KBr, νmax = cm-1): 3427, 2937, 2875, 6.91 (d, J = 10 Hz, 1H), 5.43 (dd, J = 16.5, 2.5 Hz, 1H), 3.93 (s, 3H),
8 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins